| James G Pelton, | |
|
3301 Squalicum Pkwy, Bellingham, WA 98225-1919 | |
| (360) 788-8222 | |
| (360) 788-7759 |
| Full Name | James G Pelton |
|---|---|
| Gender | Male |
| Speciality | Radiation Oncology |
| Experience | 43 Years |
| Location | 3301 Squalicum Pkwy, Bellingham, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558449918 | NPI | - | NPPES |
| 1251404 | Medicaid | WA | |
| 5876 | Other | INTERNAL ID-MOTOR VEHICLE ID |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0001X | Radiology - Radiation Oncology | MD00020032 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Overlake Hospital Medical Center | Bellevue, WA | Hospital |
| Evergreenhealth Medical Center | Kirkland, WA | Hospital |
| St Joseph Hospital | Bellingham, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Overlake Medical Clinics Llc | 7012808827 | 350 |
| King County Public Hospital District No 2 | 7618880097 | 481 |
| Peacehealth | 9537073960 | 259 |
News Archive
Starpharma Holdings Limited today announced the commencement in the U.S. of a trial to assess the safety and acceptability of SPL7013 Gel (VivaGel) in sexually active young women.
With a new $3 million grant from the National Institutes of Health, Cedars-Sinai Heart Institute investigators are moving closer to their goal of developing a biological pacemaker that can treat patients afflicted with slow heartbeats.
Preliminary results from a new study suggest that short-term sleep extension improves response time and daytime functioning of professional baseball players.
Today, several of Space City's best-known institutions - The University of Texas MD Anderson Cancer Center, the National Aeronautics and Space Administration and ILC Dover - announced a partnership that brings the benefits of arts and science to pediatric cancer patients while increasing awareness of childhood cancer.
Pall Corporation, a global leader in filtration, separation and purification, has introduced the PallSep Biotech system for the gentle separation of target molecules from complex biotechnology process fluids.
› Verified 1 days ago
| Entity Name | The Association Of University Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023041159 PECOS PAC ID: 0446162697 Enrollment ID: O20031105000244 |
News Archive
Starpharma Holdings Limited today announced the commencement in the U.S. of a trial to assess the safety and acceptability of SPL7013 Gel (VivaGel) in sexually active young women.
With a new $3 million grant from the National Institutes of Health, Cedars-Sinai Heart Institute investigators are moving closer to their goal of developing a biological pacemaker that can treat patients afflicted with slow heartbeats.
Preliminary results from a new study suggest that short-term sleep extension improves response time and daytime functioning of professional baseball players.
Today, several of Space City's best-known institutions - The University of Texas MD Anderson Cancer Center, the National Aeronautics and Space Administration and ILC Dover - announced a partnership that brings the benefits of arts and science to pediatric cancer patients while increasing awareness of childhood cancer.
Pall Corporation, a global leader in filtration, separation and purification, has introduced the PallSep Biotech system for the gentle separation of target molecules from complex biotechnology process fluids.
› Verified 1 days ago
| Entity Name | Multicare Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497766638 PECOS PAC ID: 7719899897 Enrollment ID: O20031105000760 |
News Archive
Starpharma Holdings Limited today announced the commencement in the U.S. of a trial to assess the safety and acceptability of SPL7013 Gel (VivaGel) in sexually active young women.
With a new $3 million grant from the National Institutes of Health, Cedars-Sinai Heart Institute investigators are moving closer to their goal of developing a biological pacemaker that can treat patients afflicted with slow heartbeats.
Preliminary results from a new study suggest that short-term sleep extension improves response time and daytime functioning of professional baseball players.
Today, several of Space City's best-known institutions - The University of Texas MD Anderson Cancer Center, the National Aeronautics and Space Administration and ILC Dover - announced a partnership that brings the benefits of arts and science to pediatric cancer patients while increasing awareness of childhood cancer.
Pall Corporation, a global leader in filtration, separation and purification, has introduced the PallSep Biotech system for the gentle separation of target molecules from complex biotechnology process fluids.
› Verified 1 days ago
| Entity Name | King County Public Hospital District No 2 |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801986070 PECOS PAC ID: 7618880097 Enrollment ID: O20031111000557 |
News Archive
Starpharma Holdings Limited today announced the commencement in the U.S. of a trial to assess the safety and acceptability of SPL7013 Gel (VivaGel) in sexually active young women.
With a new $3 million grant from the National Institutes of Health, Cedars-Sinai Heart Institute investigators are moving closer to their goal of developing a biological pacemaker that can treat patients afflicted with slow heartbeats.
Preliminary results from a new study suggest that short-term sleep extension improves response time and daytime functioning of professional baseball players.
Today, several of Space City's best-known institutions - The University of Texas MD Anderson Cancer Center, the National Aeronautics and Space Administration and ILC Dover - announced a partnership that brings the benefits of arts and science to pediatric cancer patients while increasing awareness of childhood cancer.
Pall Corporation, a global leader in filtration, separation and purification, has introduced the PallSep Biotech system for the gentle separation of target molecules from complex biotechnology process fluids.
› Verified 1 days ago
| Entity Name | Peacehealth |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356309553 PECOS PAC ID: 9537073960 Enrollment ID: O20031118001062 |
News Archive
Starpharma Holdings Limited today announced the commencement in the U.S. of a trial to assess the safety and acceptability of SPL7013 Gel (VivaGel) in sexually active young women.
With a new $3 million grant from the National Institutes of Health, Cedars-Sinai Heart Institute investigators are moving closer to their goal of developing a biological pacemaker that can treat patients afflicted with slow heartbeats.
Preliminary results from a new study suggest that short-term sleep extension improves response time and daytime functioning of professional baseball players.
Today, several of Space City's best-known institutions - The University of Texas MD Anderson Cancer Center, the National Aeronautics and Space Administration and ILC Dover - announced a partnership that brings the benefits of arts and science to pediatric cancer patients while increasing awareness of childhood cancer.
Pall Corporation, a global leader in filtration, separation and purification, has introduced the PallSep Biotech system for the gentle separation of target molecules from complex biotechnology process fluids.
› Verified 1 days ago
| Entity Name | Overlake Medical Clinics Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801828421 PECOS PAC ID: 7012808827 Enrollment ID: O20040322001533 |
News Archive
Starpharma Holdings Limited today announced the commencement in the U.S. of a trial to assess the safety and acceptability of SPL7013 Gel (VivaGel) in sexually active young women.
With a new $3 million grant from the National Institutes of Health, Cedars-Sinai Heart Institute investigators are moving closer to their goal of developing a biological pacemaker that can treat patients afflicted with slow heartbeats.
Preliminary results from a new study suggest that short-term sleep extension improves response time and daytime functioning of professional baseball players.
Today, several of Space City's best-known institutions - The University of Texas MD Anderson Cancer Center, the National Aeronautics and Space Administration and ILC Dover - announced a partnership that brings the benefits of arts and science to pediatric cancer patients while increasing awareness of childhood cancer.
Pall Corporation, a global leader in filtration, separation and purification, has introduced the PallSep Biotech system for the gentle separation of target molecules from complex biotechnology process fluids.
› Verified 1 days ago
| Entity Name | Peacehealth United General Medical Center |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1144664954 PECOS PAC ID: 6103056288 Enrollment ID: O20140312000236 |
News Archive
Starpharma Holdings Limited today announced the commencement in the U.S. of a trial to assess the safety and acceptability of SPL7013 Gel (VivaGel) in sexually active young women.
With a new $3 million grant from the National Institutes of Health, Cedars-Sinai Heart Institute investigators are moving closer to their goal of developing a biological pacemaker that can treat patients afflicted with slow heartbeats.
Preliminary results from a new study suggest that short-term sleep extension improves response time and daytime functioning of professional baseball players.
Today, several of Space City's best-known institutions - The University of Texas MD Anderson Cancer Center, the National Aeronautics and Space Administration and ILC Dover - announced a partnership that brings the benefits of arts and science to pediatric cancer patients while increasing awareness of childhood cancer.
Pall Corporation, a global leader in filtration, separation and purification, has introduced the PallSep Biotech system for the gentle separation of target molecules from complex biotechnology process fluids.
› Verified 1 days ago
| Entity Name | Peacehealth United General Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548698806 PECOS PAC ID: 6103056288 Enrollment ID: O20140507000955 |
News Archive
Starpharma Holdings Limited today announced the commencement in the U.S. of a trial to assess the safety and acceptability of SPL7013 Gel (VivaGel) in sexually active young women.
With a new $3 million grant from the National Institutes of Health, Cedars-Sinai Heart Institute investigators are moving closer to their goal of developing a biological pacemaker that can treat patients afflicted with slow heartbeats.
Preliminary results from a new study suggest that short-term sleep extension improves response time and daytime functioning of professional baseball players.
Today, several of Space City's best-known institutions - The University of Texas MD Anderson Cancer Center, the National Aeronautics and Space Administration and ILC Dover - announced a partnership that brings the benefits of arts and science to pediatric cancer patients while increasing awareness of childhood cancer.
Pall Corporation, a global leader in filtration, separation and purification, has introduced the PallSep Biotech system for the gentle separation of target molecules from complex biotechnology process fluids.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| James G Pelton, 1115 Se 164th Ave Dept 358, Vancouver, WA 98683-8004 Ph: (360) 729-1412 | James G Pelton, 3301 Squalicum Pkwy, Bellingham, WA 98225-1919 Ph: (360) 788-8222 |
News Archive
Starpharma Holdings Limited today announced the commencement in the U.S. of a trial to assess the safety and acceptability of SPL7013 Gel (VivaGel) in sexually active young women.
With a new $3 million grant from the National Institutes of Health, Cedars-Sinai Heart Institute investigators are moving closer to their goal of developing a biological pacemaker that can treat patients afflicted with slow heartbeats.
Preliminary results from a new study suggest that short-term sleep extension improves response time and daytime functioning of professional baseball players.
Today, several of Space City's best-known institutions - The University of Texas MD Anderson Cancer Center, the National Aeronautics and Space Administration and ILC Dover - announced a partnership that brings the benefits of arts and science to pediatric cancer patients while increasing awareness of childhood cancer.
Pall Corporation, a global leader in filtration, separation and purification, has introduced the PallSep Biotech system for the gentle separation of target molecules from complex biotechnology process fluids.
› Verified 1 days ago
Dr. Christine Myung-sook Cha, MD Radiology Medicare: Medicare Enrolled Practice Location: 3301 Squalicum Pkwy, Bellingham, WA 98225 Phone: 360-788-8222 Fax: 360-788-7759 | |
Donald Barnett, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 2901 Squalicum Pkwy, Bellingham, WA 98225 Phone: 360-734-5400 | |
Mrs. Nirbir Sandhu, RCS, CRS Radiology Medicare: Not Enrolled in Medicare Practice Location: 114 W Magnolia St Ste 505, Bellingham, WA 98225 Phone: 604-723-6750 | |
Matthew Studley, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 2930 Squalicum Pkwy, Suite #101, Bellingham, WA 98225 Phone: 360-733-0430 Fax: 360-733-0438 | |
Peter Buetow, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 2901 Squalicum Pkwy, Bellingham, WA 98225 Phone: 360-734-5400 | |
Richard Vankolken, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 2901 Squalicum Pkwy, Bellingham, WA 98225 Phone: 360-734-5400 | |
Gita R Rabbani, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 2901 Squalicum Pkwy, Bellingham, WA 98225 Phone: 360-733-0430 Fax: 360-733-0438 |